Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Maria Bohle

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Molecular Oncology|October 30, 2023
Th17 cells target the metabolic miR-142-5p-succinate dehydrogenase subunit C/D (SDHC/SDHD) axis, promoting invasiveness and progression of cervical cancersMaike Pohlers, Selina Gies, Tanja Taenzer, et al.
Hemasphere|December 16, 2020
Indeterminate Dendritic Cell Tumor With Persistent Complete Metabolic Response to BRAF/MEK InhibitionLorenz Thurner, Moritz Bewarder, Florian Rosar, et al.
International Journal of Cancer|January 24, 2026
Th17 cells favor migration and invasiveness of cervical cancer cells under hypoxia in an IGF2BP2-dependent mannerSelina Gies, Maike Pohlers, Tanja Tänzer, et al.
Journal of Autoimmunity|November 15, 2012
Progranulin antibodies in autoimmune diseasesLorenz Thurner, Klaus-Dieter Preuss, Natalie Fadle, et al.
Cancer Research|May 25, 2016
STAT3/IRF1 Pathway Activation Sensitizes Cervical Cancer Cells to Chemotherapeutic DrugsBarbara Walch-Rückheim, Jennifer Pahne-Zeppenfeld, Jil Fischbach, et al.
Molecular Oncology|September 1, 2021
Chemoradiotherapy-induced increase in Th17 cell frequency in cervical cancer patients is associated with therapy resistance and early relapseLaura Theobald, Russalina Stroeder, Patrick Melchior, et al.
Leukemia|June 30, 2018
LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targetingLorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
Nature Communications|May 20, 2020
Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphomaLorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
Ejhaem|September 2, 2022
B-cell receptors of EBV-negative Burkitt lymphoma bind modified isoforms of autoantigensTheresa Bock, Moritz Bewarder, Onur Cetin, et al.
Haematologica|May 4, 2023
B-cell receptor reactivity against <i>Rothia mucilaginosa</i> in nodular lymphocyte-predominant Hodgkin lymphomaLorenz Thurner, Natalie Fadle, Evi Regitz, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Molecular Oncology|October 30, 2023
Th17 cells target the metabolic miR-142-5p-succinate dehydrogenase subunit C/D (SDHC/SDHD) axis, promoting invasiveness and progression of cervical cancersMaike Pohlers, Selina Gies, Tanja Taenzer, et al.
Hemasphere|December 16, 2020
Indeterminate Dendritic Cell Tumor With Persistent Complete Metabolic Response to BRAF/MEK InhibitionLorenz Thurner, Moritz Bewarder, Florian Rosar, et al.
International Journal of Cancer|January 24, 2026
Th17 cells favor migration and invasiveness of cervical cancer cells under hypoxia in an IGF2BP2-dependent mannerSelina Gies, Maike Pohlers, Tanja Tänzer, et al.
Journal of Autoimmunity|November 15, 2012
Progranulin antibodies in autoimmune diseasesLorenz Thurner, Klaus-Dieter Preuss, Natalie Fadle, et al.
Cancer Research|May 25, 2016
STAT3/IRF1 Pathway Activation Sensitizes Cervical Cancer Cells to Chemotherapeutic DrugsBarbara Walch-Rückheim, Jennifer Pahne-Zeppenfeld, Jil Fischbach, et al.
Molecular Oncology|September 1, 2021
Chemoradiotherapy-induced increase in Th17 cell frequency in cervical cancer patients is associated with therapy resistance and early relapseLaura Theobald, Russalina Stroeder, Patrick Melchior, et al.
Leukemia|June 30, 2018
LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targetingLorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
Nature Communications|May 20, 2020
Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphomaLorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
Ejhaem|September 2, 2022
B-cell receptors of EBV-negative Burkitt lymphoma bind modified isoforms of autoantigensTheresa Bock, Moritz Bewarder, Onur Cetin, et al.
Haematologica|May 4, 2023
B-cell receptor reactivity against <i>Rothia mucilaginosa</i> in nodular lymphocyte-predominant Hodgkin lymphomaLorenz Thurner, Natalie Fadle, Evi Regitz, et al.
Pageof 5